ÂÜÀòÂÒÂ×

Andrew T. Basso has extensive experience in the biopharmaceutical and medical device industries, currently serving as the Senior Director of Compounding Operations at Fagron Sterile Services US since September 2016. Basso's leadership expertise encompasses overseeing operations at cGMP 503B Outsourcing Facilities, with a focus on delivering sterile medications and a diverse portfolio of preparations. Previous roles include Executive Director of Technical Operations and Technology Transfer at Anika Therapeutics, where Basso managed significant capital projects and operational teams across multiple countries. With a background that includes founding Bioresource Technology Inc. and holding various directorial positions at Serologicals, Bayer Diagnostics, Chiron Corporation, and Novartis, Basso has a proven track record in driving growth, operational efficiency, and innovation in the pharmaceutical landscape. Basso holds a Bachelor of Science and an Executive MBA from the University of Rhode Island.